A Review of a Multicenter Trial of a Tubeless, On-Body Automated Insulin Delivery System With Customizable Glycemic Targets in Pediatric and Adult Participants With Type 1 Diabetes

This publication is sponsored by Insulet Corporation.

This Clinical Brief provides key information regarding the results of a pivotal clinical trial of a tubeless, on-body automated insulin delivery system in pediatric and adult patients with type 1 diabetes. An interview with trial investigators offers insights on the impact of advances in technology on disease management and treatment.

Stay ahead of policy, cost, and value—subscribe to AJMC for expert insights at the intersection of clinical care and health economics.

A Review of a Multicenter Trial of a Tubeless, On-Body Automated Insulin Delivery System With Customizable Glycemic Targets in Pediatric and Adult Participants With Type 1 Diabetes

Trending on AJMC

FDA Approves Enlicitide, First Oral PCSK9 for High Cholesterol

SYNCHRONIZE-1 Through a Hepatologist's Lens: Liver Fat Reduction, Visceral Fat, and What Comes Next

Stem Cell Transplant Outperforms DMTs in Drug-Resistant Relapsing MS

Deep Learning Model Matches Expert Agreement in Sleep Arousal Scoring

AI Phenotyping Links Cardiovascular, Kidney Disease to Rapid MASH Progression, Higher Costs